Amprenavir en es it fr

Amprenavir Brand names, Amprenavir Analogs

Amprenavir Brand Names Mixture

  • No information avaliable

Amprenavir Chemical_Formula


Amprenavir RX_link

Amprenavir fda sheet

Amprenavir FDA

Amprenavir msds (material safety sheet)

Amprenavir Synthesis Reference

No information avaliable

Amprenavir Molecular Weight

505.628 g/mol

Amprenavir Melting Point

No information avaliable

Amprenavir H2O Solubility

No information avaliable

Amprenavir State


Amprenavir LogP


Amprenavir Dosage Forms


Amprenavir Indication

For the treatment of HIV-1 infection in combination with other antiretroviral agents.

Amprenavir Pharmacology

Amprenavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Amprenavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.

Amprenavir Absorption

No information avaliable

Amprenavir side effects and Toxicity

No information avaliable

Amprenavir Patient Information

Amprenavir Organisms Affected

Human immunodeficiency virus